1. Zeppenfeld K, Tfelt-Hansen J,Riva M, et al. ESC Scientific Document Group, 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC). European Heart Journal. 2022;43(40): 3997-4126. DOI: 10.1093/eurheartj/ehac262
2. Лебедев ДС, Михайлов ЕН, Неминущий НМ., и др. Желудочковые нарушения ритма. Желудочковые тахикардии и внезапная сердечная смерть. Клинические рекомендации 2020. Российский кардиологический журнал. 2021;26(7): 4600.
Lebedev DS, Mikhailov EN, Neminuschiy NM, et al. Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines. Russian Journal of Cardiology. 2021;26(7): 4600. (In Russ.). DOI: 10.15829/1560-4071-2021-4600
3. Haris M. Haqqani MBBS(Hons), David J. Callans MD. Ventricular Tachycardia in Coronary Artery Disease. Cardiac Electrophysiology Clinics. 2014;6(3): 525-534.
4. Liuba I, Frankel DS, Riley MP, et al. Scar progression in patients with nonischemic cardiomyopathy and ventricular arrhythmias. Heart Rhythm. 2014;11(5): 755-762. DOI: 10.1016/j.hrthm.2014.02.012
5. Thomas H, Diamond J, Vieco A, et al. Global Atlas of Cardiovascular Disease 2000-2016: the path to prevention and control. Glob Heart 2018;13: 143-63. DOI: 10.1016/j.gheart.2018.09.511
6. Eckart RE, Shry EA, Burke AP, et al. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol. 2011;58: 1254-61. DOI: 10.1016/j.jacc.2011.01.049
7. Samuel M, Elsokkari I, Sapp JL. Ventricular Tachycardia Burden and Mortality: Association or Causality? Can J Cardiol. 2022;38(4): 454-464. DOI: 10.1016/j.cjca.2022.01.016
8. Deyell MW, AbdelWahab A, Angaran P, et al. 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society position statement of the management of ventricular tachycardia and fibrillation in patients with structural heart disease. Can J Cardiol. 2020;36: 822-36. DOI: 10.1016/j.cjca.2020.04.004
9. Alvarez CK, Cronin E, Baker WL, Kluger J. Heart failure as a substrate and trigger for ventricular tachycardia. J Interv Card Electrophysiol. 2019;56(3): 229-247. DOI: 10.1007/s10840-019-00623-x
10. Галявич АС, Терещенко СН, Ускач ТМ, и др. Хроническая сердечная недостаточность. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(11): 6162.
Galyavich AS, Tereshchenko SN, Uskach TM, et al. 2024 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2024;29(11): 6162. (In Russ.). DOI: 10.15829/1560-4071-2024-6162
11. Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359: 1009-17. DOI: 10.1056/NEJMoa071098
12. Powell BD, Saxon LA, Boehmer JP, et al. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. J Am Coll Cardiol. 2013;62: 1674-1679. DOI: 10.1016/j.jacc.2013.04.083
13. Kamphuis HC, de Leeuw JR, Derksen R, et al. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study. Europace. 2003;5: 381-9. DOI: 10.1016/s1099-5129(03)00078-3
14. Reddy VY, Reynolds MR, Neuzil P., et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357: 2657-2665. DOI: 10.1056/NEJMoa065457
15. Pandian J, Kaur D, Yalagudri S, et al. Safety and efficacy of epicardial approach to catheter ablation of ventricular tachycardia - An institutional experience. Indian Heart J. 2017; 69 (2): 170-175. DOI: 10.1016/j.ihj.2016.10.010
16. Михайлов ЕН, Гасымова НЗ, Айвазьян СА, и др. Факторы, ассоциированные с эффективностью радиочастотной катетерной аблации фибрилляции предсердий: мнение специалистов, применяющих технологию “Индекс Аблации”. Вестник аритмологии. 2020;27(3): 9-24.
Mikhaylov EN, Gasimova NZ, Ayvazyan SA, et al. Factors associated with the efficacy of atrial fibrillation radiofrequency catheter ablation: opinion of the specialists who use the “ablation index” module. Journal of Arrhythmology. 2020;27(3): 9-24. (In Russ.). DOI: 10.35336/VA-2020-3-9-24
17. Артюхина ЕА, Сатинбаев ЗИ. Катетерная аблация с использованием технологии “индекс аблации”. Анналы аритмологии. 2022;19(1): 32-38.
Artyukhina, EA, Satinbaev ZI Catheter ablation using the “ablation index” technology. Annals of Arrhythmology. 2022;19(1): 32-38 (In Russ). DOI: 10.15275/annaritmol.2022.1.5
18. Liu Z, Liu L-f, Liu X-q, et al. Ablation index-guided ablation with milder targets for atrial fibrillation: Comparison between high power and low power ablation. Cardiovasc. Med. 2022:9:949918. DOI: 10.3389/fcvm.2022.94991
19. Qin X, Jiang X, Yuan Q, et al. Optimal ablation index parameters for radiofrequency ablation therapy of atrial fibrillation. Pak J Med Sci. 2022;38(3): 632-638.:. DOI: 10.12669/pjms.38.3.4971
20. Sciacca V, Vogler J, Eitel C, et al. Ablation index-guided catheter ablation of incessant ventricular tachycardia originating from the anterolateral papillary muscle. Clin Res Cardiol. 2022;111(5): 588-591. DOI: 10.1007/s00392-021-01923-x
21. Younis A, Zilberman I, Yavin H, et al. Utility and Limitations of Ablation Index for Guiding Therapy in Ventricular Myocardium. JACC Clin Electrophysiol. 2023;9(8 Pt 3): 1668-1680. DOI: 10.1016/j.jacep.2023.03.02
22. Pothineni NVK, Garcia FC, Santangeli P. Radiofrequency Ablation Strategies for Intramural Ventricular Arrhythmias. Methodist Debakey Cardiovasc J. 2021;17(1): 8-12. DOI: 10.14797/PEYF3776
23. Nazarian S, Bluemke DA, Lardo AC, et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation. 2005;112(18): 2821-2825. DOI: 10.1161/CIRCULATIONAHA.105.549659
24. Guandalini GS, Liang JJ, Marchlinski FE. Ventricular Tachycardia Ablation: Past, Present, and Future Perspectives. JACC Clin Electrophysiol. 2019;5(12): 1363-1383. DOI: 10.1016/j.jacep.2019.09.015
25. Королев СВ, Артюхина ЕА, Шабанов ВВ, и др. Сравнительная оценка результатов проспективного регистра радиочастотной абляции высокой мощности желудочковых нарушений ритма у пациентов с ишемической болезнью сердца. Вестник Национального медико-хирургического Центра им. Н. И. Пирогова. 2023;18(1): 28-35.
Korolev SV, Artyukhina EA, Shabanov VV, et al.Comparative evaluation of the results of a prospective registry of high-power radiofrequency ablation of ventricular arrhythmia in patients with coronary heart disease. Bulletin of the National Medical and Surgical Center N. I. Pirogov. 2023;18(1): 28-35 (In Russ). DOI: 10.25881/20728255_2023_18_1_28
26. Королев СВ, Артюхина ЕА, Шабанов ВВ, и др. Радиочастотная аблация высокой мощности при лечении желудочковых тахикардий у пациентов со структурной патологией сердца: результаты одного года наблюдения многоцентрового проспективного регистра. Патология кровообращения и кардиохирургия. 2023;27(2): 66-73.
Korolev SV, Artyukhina EA, Shabanov VV, et al. High-power radiofrequency ablation for ventricular tachycardia in patients with structural heart disease:one-year follow-up data from the multicenter prospective registry. Circulatory pathology and cardiac surgery. 2023;27(2): 66-73 (In Russ). DOI: 10.21688/1681-3472-2023-2-66-73
27. Phlips T, Taghji P, El Haddad M et al. Improving procedural and one-year outcome after contact force-guided pulmonary vein isolation: the role of interlesion distance, ablation index, and contact force variability in the ‘CLOSE’-protocol. Europace. 2018;20(3): f419-f427.